Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
What amino acid is NE derived from?
|
Tyrosine!
|
|
What decarboxylase cofactor is associated with NE biosynthesis?
|
PLP
|
|
What enzyme provides a major route of regulation/degradation for NE?
|
MAO (monoamine oxidase)
|
|
Is the following enzyme associated with biosynthesis or degradation of NE?
MAO (monoamine oxidase) |
Degradation
|
|
Is the following enzyme associated with biosynthesis or degradation of NE?
COMT (catechol-O-methyltranserase) |
Degradation
|
|
Are the following enzymes associated with biosynthesis or degradation of NE?
aldehyde reductase, aldehyde dehydrogenase |
Degradation
|
|
Is the following enzyme associated with biosynthesis or degradation of NE?
Tyrosine hydroxylase |
Biosynthesis
|
|
Is the following enzyme associated with biosynthesis or degradation of NE?
Dopamine beta-hydroxylase |
Biosynthesis
|
|
Which type of agonist is used as a bronchodilater and to treat glaucoma?
|
beta-2
|
|
Which type of agonist is used for treatment of hypertension, glaucoma, analgesia and used as a sedative?
|
alpha-2
|
|
Which type of antagonist is used for treatment of hypertension and benign prostate hyperplasia?
|
alpha-1
|
|
Which type of antagonist is used to treat hypertension and arrythmias?
|
beta-1 (beta blockers)
|
|
Where are alpha-1 receptors found and what do they stimulate?
|
Vascular smooth muscle; stimulate IP3 via Gq protein coupled receptor
|
|
Where are alpha-2 receptors found?
|
Found on vascular smooth muscle, sympathetic nerve terminals and pre-synaptic neurons
|
|
Where are beta-1 receptors found and what do they stimulate?
|
Cardiac nodal tissue, conducting system and contracting myoctyes; they stimulate contraction via a G-protein coupled receptor
|
|
Where are beta-2 receptors found?
|
Cardiac nodal tissue, conducting system and contracting myoctyes as well as vascular smooth muscle
|
|
Why was colterol a poor drug candidate?
|
It had poor bioavailability because the catechol group was rapidly metabolized via COMT and sulfotransferases.
|
|
What structure makes a beta blocker a beta blocker (i.e. confers beta-1 specificity)?
|
A single phenol ring with a para substitution
|
|
What important intermediate do beta-haloalkylamines form?
|
Aziridinium ion
|
|
True or False: Beta-haloalkylamines react with receptors via a covalent mechanism.
|
True
|
|
What type of receptor do beta-haloalkylamines act on? Do they act as agonists or antagonists?
|
Adrenergic receptors (non-selective); antagonists
|
|
What types of substances do beta-haloalkylamines block?
|
Primarily NE, but also acetylcholine, histamine and seratonin (acts as an irreversible antagonist on all of these)
|
|
What other effect do beta-haloalkylamines have other than blocking receptors?
|
They can lead to downstream protein degredation by proteasome.
|
|
True or false: imidazolines only form covalent actions.
|
False; non-covalent interactions only (and thus reversible)
|
|
What physiologic responses do imidazolines produce?
|
Vasodilation and reflex tachydardia; may promote release of NE
|
|
Which alpha receptor are imidazolines specific for?
|
Neither (trick question!)
|
|
Why is the half-life of prazosin shorter than that of terazosin and doxazosin?
|
Prazosin has a more electron rich-structure and thus is better substrate for metabolizing enzymes.
|
|
Which receptor are the quinazolines specific for? Are they agonists or antagonists?
|
alpha-1 antagonists
|
|
Which receptor are the Ergot alkaloids specific for? Are they agonists or antagonists?
|
alpha (non-specific) antagonists
|
|
What is methylsergide used for?
|
To treat migraines.
|